Ecofriendly Fabrication of Modified Graphene Oxide Latex Nanocomposites with High Oxygen Barrier Performance.

Large-scale industrial applications of barrier films and coatings that prevent permeation of degradative gases and moisture call for the development of cost-efficient and ecofriendly polymer nanocomposites. Herein, we report the facile fabrication of latex nanocomposites (LNCs) by incorporating surface-modified graphene oxide (mGO) at various loadings (0.025-1.2 wt %) into a styrene-acrylic latex using water as the processing solvent. LNCs fabricated with mGO exhibited significant reductions (up to 67%) in water vapor sorption, resulting in greater environmental stability when compared to LNCs fabricated with equivalent loading of hydrophilic, unmodified GO. The assembly and coalescence of the exfoliated latex/mGO dispersions during the film formation process produced highly dispersed and well-ordered mGO domains with high aspect ratios, where alignment and overlap of the mGO domains improved with increasing mGO content. The addition of only 0.7 vol % (1.2 wt %) mGO led to an 84% decrease (relative to the neat polymer latex film) in oxygen permeability of the LNC films, an excellent barrier performance attributed to the observed LNC film morphologies. This work enables ecofriendly development of mechanically flexible mGO/LNC films with superior barrier properties for many industrial applications including protective coatings, food packaging, and biomedical products.

Genome Sequence of Mycobacterium Phage Waterfoul.

Waterfoul is a newly isolated temperate siphovirus of Mycobacterium smegmatis mc2155. It was identified as a member of the K5 cluster of Mycobacterium phages and has a 61,248-bp genome with 95 predicted genes.

Destruction of Opportunistic Pathogens via Polymer Nanoparticle-Mediated Release of Plant-Based Antimicrobial Payloads.

The synthesis of antimicrobial thymol/carvacrol-loaded polythioether nanoparticles (NPs) via a one-pot, solvent-free miniemulsion thiol-ene photopolymerization process is reported. The active antimicrobial agents, thymol and carvacrol, are employed as "solvents" for the thiol-ene monomer phase in the miniemulsion to enable facile high capacity loading (≈50% w/w), excellent encapsulation efficiencies (>95%), and elimination of all postpolymerization purification processes. The NPs serve as high capacity reservoirs for slow-release and delivery of thymol/carvacrol-combination payloads that exhibit inhibitory and bactericidal activity (>99.9% kill efficiency at 24 h) against gram-positive and gram-negative bacteria, including both saprophytic (Bacillus subtilis ATCC 6633 and Escherichia coli ATCC 25922) and pathogenic species (E. coli ATCC 43895, Staphylococcus aureus RN6390, and Burkholderia cenocepacia K56-2). This report is among the first to demonstrate antimicrobial efficacy of essential oil-loaded nanoparticles against B. cenocepacia - an innately resistant opportunistic pathogen commonly associated with debilitating respiratory infections in cystic fibrosis. Although a model platform, these results point to promising pathways to particle-based delivery of plant-derived extracts for a range of antimicrobial applications, including active packaging materials, topical antiseptics, and innovative therapeutics.

Functional, composite polythioether nanoparticles via thiol-alkyne photopolymerization in miniemulsion.

Thiol-yne photopolymerization in miniemulsion is demonstrated as a simple, rapid, and one-pot synthetic approach to polythioether nanoparticles with tuneable particle size and clickable functionality. The strategy is also useful in the synthesis of composite polymer-inorganic nanoparticles.

Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro.

Dengue virus (DENV) infection in humans can cause flu-like illness, life-threatening haemorrhagic fever or even death. There is no specific anti-DENV therapeutic or approved vaccine currently available, partially due to the possibility of antibody-dependent enhancement reaction. Small interfering RNAs (siRNAs) that target specific viral genes are considered a promising therapeutic alternative against DENV infection. However, in vivo, siRNAs are vulnerable to degradation by serum nucleases and rapid renal excretion due to their small size and anionic character. To enhance siRNA delivery and stability, we complexed anti-DENV siRNAs with biocompatible gold nanoparticles (AuNPs) and tested them in vitro. We found that cationic AuNP-siRNA complexes could enter Vero cells and significantly reduce DENV serotype 2 (DENV-2) replication and infectious virion release under both pre- and post-infection conditions. In addition, RNase-treated AuNP-siRNA complexes could still inhibit DENV-2 replication, suggesting that AuNPs maintained siRNA stability. Collectively, these results demonstrated that AuNPs were able to efficiently deliver siRNAs and control infection in vitro, indicating a novel anti-DENV strategy.